Patents by Inventor Michael Stocks

Michael Stocks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6278555
    Abstract: A laser scanning microscope with raster-type illumination at different wavelengths comprises laser radiation which is coupled in by light-conducting fibers, wherein the coupling in of the illumination is carried out by at least one dichroic beam splitter which reflects in at least one wavelength range and transmits in at least a second wavelength range.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: August 21, 2001
    Assignee: Carl Zeiss Jena GmbH
    Inventors: Michael Stock, Ulrich Simon, Ralf Wolleschensky
  • Patent number: 6265409
    Abstract: The invention relates to novel pyridyl derivatives, their use as medicaments, pharmaceutical formulations including them and methods for their preparation.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: July 24, 2001
    Assignee: AstraZeneca AB
    Inventors: David Cheshire, David Cladingboel, Simon Hirst, Carol Manners, Michael Stocks
  • Patent number: 6143751
    Abstract: Compounds of the formula (I) wherein X, R.sup.1, R.sup.2, and Ar.sup.1 as defined in the specification. The compounds are useful medicaments, particularly in the treatment of asthma or rhinitis.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: November 7, 2000
    Assignee: AstraZeneca UK Limited
    Inventors: David Cheshire, David Cladinggboel, Martin Cooper, David Hardern, Simon Hirst, Carol Manners, Michael Stocks
  • Patent number: 5977105
    Abstract: A compound of formula I, ##STR1## wherein--X represents (CH.sub.2).sub.n O, (CH.sub.2).sub.n S or C.sub.2 alkylene;n represents 1 or 2;Ar.sup.1 represents indanyl, tetrahydronaphthyl, naphthyl or phenyl, which latter two groups may be substituted by one or more substituents selected from chloro, fluoro, OR.sup.1, O(CH.sub.2).sub.m CONR.sup.20 R.sup.21, C(O)R.sup.2, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), pyridyl, thiazinyl, phenyl or C.sub.7-9 alkylphenyl which latter two groups are optionally substituted by one or more substituent selected from halo, nitro, OR.sup.3, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), C(O)R.sup.4, C(O)OR.sup.5, C(O)N(R.sup.6)R.sup.7, CN, CH.sub.2 OR.sup.14, CH.sub.2 NR.sup.15 R.sup.16, N(R.sup.8)R.sup.9, N(R.sup.10)SO.sub.2 R.sup.11, N(R.sup.12)C(O)R.sup.13, OC(O)R.sup.19 and SO.sub.2 NR.sup.17 R.sup.18 ;m represents an integer 1 to 3;R.sup.1, R.sup.2 and R.sup.3 independently represent H, C.sub.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: November 2, 1999
    Assignee: Astra Pharmaeuticals Ltd.
    Inventors: David Cheshire, David Cladingboel, David Hardern, Michael Stocks